Table 3.

Multivariate survival analyses of all-cause mortality and competing risk of cardiovascular death.

	Cox proportional model*	Cause-specific model*	Subdistribution model*
Ln PAC	1.09 (1.06‒1.12, p < 0.001)	1.13 (1.05‒1.22, p = 0.001)	1.12 (1.04‒1.21, p = 0.004)
PAC < 4	–	–	–
4 ≤ PAC < 16	1.03 (0.78‒1.36, p = 0.830)	0.90 (0.43‒1.90, p = 0.787)	0.89 (0.42‒1.87, p = 0.760)
16 ≤ PAC < 77	1.25 (0.96‒1.62, p = 0.094)	1.36 (0.70‒2.65, p = 0.364)	1.37 (0.69‒2.74, p = 0.360)
PAC ≥ 77	1.67 (1.29‒2.15, p < 0.001)	1.88 (0.99‒3.59, p = 0.055)	1.82 (0.92‒3.62, p = 0.088)

*Adjusted for age, gender, DM, hypertension, CAD, CKD, HF, stroke, aspirin, and ACEi/ARB.

Abbreviations: ACEi/ARB angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, CAD coronary artery disease, CKD chronic kidney disease, DM diabetes mellitus, HF heart failure, HR hazard ratio, PAC premature atrial complex.